Artemis-euproject
@artemis-euproject.bsky.social
🌍 Artemis EU Project – EU-funded initiative connecting science, technology & innovation for a sustainable future. Focus: innovation, education & collaboration. 👉 artemis-euproject.eu
New study in Cell Systems — partially funded by #ARTEMIs (WP5) — reveals how common painkillers may contribute to anemia in cancer patients.
Researchers uncovered a mechanism with important clinical implications.
www.sciencedirect.com/science/arti...
www.dkfz.de/en/news/pres...
Researchers uncovered a mechanism with important clinical implications.
www.sciencedirect.com/science/arti...
www.dkfz.de/en/news/pres...
Diclofenac and acetaminophen dim the acute-phase response but amplify expression of the iron regulator hepcidin in liver cancer cells
Cancer patients frequently suffer from anemia and cancer-related pain, which can be treated by non-opioid analgesics such as diclofenac (DCF) and acet…
www.sciencedirect.com
December 11, 2025 at 2:08 PM
New study in Cell Systems — partially funded by #ARTEMIs (WP5) — reveals how common painkillers may contribute to anemia in cancer patients.
Researchers uncovered a mechanism with important clinical implications.
www.sciencedirect.com/science/arti...
www.dkfz.de/en/news/pres...
Researchers uncovered a mechanism with important clinical implications.
www.sciencedirect.com/science/arti...
www.dkfz.de/en/news/pres...
"With its innovative use of virtual twins, ARTEMIs brings hope for earlier interventions, fewer complications, and improved quality of life for patients." Milan Mishkovikj, ELPA Board Member
🔗 artemis-euproject.eu
🔗 artemis-euproject.eu
November 24, 2025 at 8:49 AM
"With its innovative use of virtual twins, ARTEMIs brings hope for earlier interventions, fewer complications, and improved quality of life for patients." Milan Mishkovikj, ELPA Board Member
🔗 artemis-euproject.eu
🔗 artemis-euproject.eu
"ARTEMIs will empower doctors with better tools to personalise care, ensuring patients receive the right treatment at the right time." Tove Frisch
ARTEMIs brings together science, innovation, and patient voices to transform the future of liver and heart health.
Learn more: artemis-euproject.eu
ARTEMIs brings together science, innovation, and patient voices to transform the future of liver and heart health.
Learn more: artemis-euproject.eu
November 19, 2025 at 11:10 AM
"ARTEMIs will empower doctors with better tools to personalise care, ensuring patients receive the right treatment at the right time." Tove Frisch
ARTEMIs brings together science, innovation, and patient voices to transform the future of liver and heart health.
Learn more: artemis-euproject.eu
ARTEMIs brings together science, innovation, and patient voices to transform the future of liver and heart health.
Learn more: artemis-euproject.eu
💡 Did you know?
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU
September 4, 2025 at 5:55 AM
💡 Did you know?
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU
💡 Did you know?
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU
September 4, 2025 at 5:54 AM
💡 Did you know?
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU
Did you know?
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine
September 4, 2025 at 5:40 AM
Did you know?
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine
💡 Did you know?
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU
September 4, 2025 at 5:39 AM
💡 Did you know?
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU
🚨 Revolutionizing liver healthcare! ARTEMIS is using virtual twins & digital modeling to fight #MASLD and improve patient lives. 🌍💡✨ #InnovationInMedicine #LiverHealth
September 4, 2025 at 5:38 AM
🚨 Revolutionizing liver healthcare! ARTEMIS is using virtual twins & digital modeling to fight #MASLD and improve patient lives. 🌍💡✨ #InnovationInMedicine #LiverHealth
🚨 The future of liver healthcare is here! 🌍🧬
Watch how ARTEMIS EU Project uses virtual twins to fight #MASLD, a disease affecting 1 in 4 Europeans.
🎥 youtu.be/SW1rIpcZcI8
With top scientists, clinicians & ELPA, we’re shaping personalized liver care. 💡✨
#LiverHealth
Watch how ARTEMIS EU Project uses virtual twins to fight #MASLD, a disease affecting 1 in 4 Europeans.
🎥 youtu.be/SW1rIpcZcI8
With top scientists, clinicians & ELPA, we’re shaping personalized liver care. 💡✨
#LiverHealth
ARTEMiS- The Power of Virtual Twins to Fight MASLD
YouTube video by ARTEMIS Project
www.youtube.com
September 4, 2025 at 5:35 AM
🚨 The future of liver healthcare is here! 🌍🧬
Watch how ARTEMIS EU Project uses virtual twins to fight #MASLD, a disease affecting 1 in 4 Europeans.
🎥 youtu.be/SW1rIpcZcI8
With top scientists, clinicians & ELPA, we’re shaping personalized liver care. 💡✨
#LiverHealth
Watch how ARTEMIS EU Project uses virtual twins to fight #MASLD, a disease affecting 1 in 4 Europeans.
🎥 youtu.be/SW1rIpcZcI8
With top scientists, clinicians & ELPA, we’re shaping personalized liver care. 💡✨
#LiverHealth